CREATE AN
ACCOUNT VIRTUAL
DISPLAY HALL

Pharmacology

Meet your national and state pharmacology credit requirements with recordings from NPACE’s live pharmacology conferences. These sessions will help you improve or maintain prescribing skills as well as stay current with the latest in pharmacotherapeutics. 

You may filter by category, such as women’s health or diabetes, alphabetically or by date. Click the “View” button to read the Course Description, Course Objectives, Speaker information, CNE Information and Disclosures. 

Like what you see? Click “Register” and follow instructions to view the video recording for up to one year. Successful completion of the post-test is required for CE units to be granted.

On-Demand Pharmacology CE

Search by Type
Sort By
Search by Favorites

113 Results

  • (DEA) MATE Act - Substance Use Disorder Bundle V2

    In accordance with the Medication Access and Training Expansion (MATE) Act, beginning June 7, 2023, all providers who are registered with the DEA are required to complete 8 hours of training on the treatment and management of patients with opioid and other substance use disorders. This bundle fully satisfies this one-time requirement. 

    Total Credits: 9.00 contact hours; 8.5 are pharmacology
    Expiration Date: June 30, 2025
    $225 

  • Addressing Barriers in Vaccination Uptake and Integration

    Merck Grant Funded Program

    The overall goal of this program is to address the barriers in vaccination uptake and integration. 

    Credits: 1.0 contact hours; 1.0 are Pharmacology

    Expiration Date: December 31st, 2025

    $10.00

  • Adolescent Substance Use Disorder

    Adolescent substance use has followed familiar trends for several decades with alcohol, nicotine, and cannabis leading other drugs in popularity. After several years of declining nicotine use, primarily via combustible cigarettes, recent data suggests a resurgence of nicotine use, primarily via e-cigarettes as well as a marked increase in cannabis use, likely corresponding with legalization efforts. Additionally, there has been an increase in hallucinogen use and the dangers of opioid use have heightened due to the rise of illicit fentanyl being brought in from outside the United States. This lecture will review the most recent Monitoring the Future study and discuss implications of adolescent substance use trends on healthcare providers.

    *Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education. 

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology
    Expiration Date: December 31st, 2025

    $40

  • Adult Immunization Update 2024

    "Supported by an educational grant from Merck"

    This is a up to date and in depth session discussing the current guidelines for the adult immunization schedule. Discussing the current evidence supporting the need for immunizations and the numbers of illness in the US. Risks and Benefits of immunizations, and myths surrounding immunizations. Every year updated vaccination schedules are provided to guide immunization practices. Keeping up with these updates is often difficult. This session will review changes and updates to the 2024 adult schedule.

    *Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.

    Credits: 1.0 Contact Hours; 1.0 are Pharmacology
    Expiration Date: December 31, 2025
    $35

  • Analyzing Existing Evidence to Inform Appropriate Use of Antivirals for Influenza and COVID-19 Infections

    Influenza and COVID-19 are both respiratory illnesses that can cause serious complications, especially in high-risk populations. Nurse practitioners play a key role in the diagnosis and treatment of influenza and COVID-19 infections. This presentation will evaluate the different types of antiviral medications and their pharmacologic features. Patient populations who are most likely to benefit from antiviral therapy will be reviewed. This presentation will examine the most up to date evidence related to efficacy and safety of antivirals for influenza and COVID-19, and provide an approach to the appropriate use of these medications in clinical practice.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology

    $40

  • An Evidence-Based Approach to Maximizing Benefit & Limiting Antibiotic Risks in Community-Acquired Pneumonia

    In 2019, the Infectious Disease Society of America and American Thoracic Society published updated recommendations for managing patients with community-acquired pneumonia (CAP) generating new considerations for inpatient and outpatient practitioners. This presentation will assess emerging literature influencing the optimal pharmacologic management of CAP such as, changing etiologic trends, patient-specific factors, outcomes evidence, and risk factors for adverse drug reactions.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology
    Expiration Date: December 31st, 2025

    $15.00

  • Antibiotics in Outpatient Care - What's New & What's Not

    The presentation will discuss the factors involved in the appropriate use of antibiotics in the outpatient setting including the differential diagnosis of several common infections.

     *Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology
    Expiration Date: June 30, 2025 
    $40

  • Antibiotic Update 2023: Respiratory Infections in the Challenging Patient

    This session will provide the nurse practitioner with information regarding common pathogens implicated in AECB and community acquired pneumonia in the patient with underlying co-morbidities such as asthma, COPD and alcohol abuse.  Current recommendations regarding antimicrobial treatment options will be reviewed in detail.  National recommendations for obtaining chest x-ray and sputum for gram staining will also be discussed.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology
    Expiration Date: December 31st, 2025

    $45

  • Anxiously Awaited: Neurobiology & Personalized Treatment of Anxiety

    Updated diagnostic criteria and disease models for anxiety disorders are reviewed. Neurobiological and epigenetic mechanisms that underlie anxiety symptoms are presented as the basis for therapeutic interventions. Specific attention is given to the formulation of rational, genomically-informed pharmacologic treatment approaches for anxiety disorders. Practical applications for nurse practitioners are presented.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology
    $40

  • Atrial Fibrillation-Importance, recognition, and treatment

    Atrial fibrillation (AF) remains the most common heart arrhythmia in the general population and is associated with significant morbidity and mortality. Appropriate identification and treatment are critical to prevent potential devastating sort-and long-term outcomes. Practitioners in all areas of practice will encounter patients with various stages of AF, and therefore must be able to identify, classify and treat this common arrhythmia. This session will focus on the classification of AF, identification and various treatment and preventative options.

    Credits: 1.50 contact hours; 0.75 are pharmacology
    Expiration Date: December 31st, 2025
    $15.00